Protea Biosciences Group Inc. reported earnings results for the first quarter 2016. The company reported revenue of $475,338, a 22% increase over the revenue reported for the first quarter of 2015. Revenue increases were posted for all business lines. The loss from operations for the first quarter 2016 was $1,566,051, a decrease of 27% compared to a loss from operations of $2,144,529 for the first quarter of 2015. Net cash used in operating activities for the three months ended March 31, 2016 totaled $1,296,505, a decrease of $140,683 or a 10% reduction in the net cash used in operations for the three months ended March 31, 2015.